Dr. Reddy's Laboratories LimitedRDY
Price as of · delayed, not real-time
A global pharmaceutical company based in Hyderabad, India, with a diversified portfolio spanning generic drugs, biosimilars, active pharmaceutical ingredients, and consumer healthcare products. It operates across more than 60 countries, with a strong presence in the U.S. and emerging markets, and is among the top generic drug manufacturers worldwide. Investors track it for its pipeline of complex generics and biosimilars, as well as its exposure to pricing pressures in the U.S. generic market.
Congressional Interest in Dr. Reddy's Laboratories Limited (RDY)
3 members of Congress have disclosed 3 trades in Dr. Reddy's Laboratories Limited (RDY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading RDY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-11-20 | MIKE KELLY | sell | $1K-$15K |
| 2010-12-10 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2009-02-03 | JANE HARMAN | buy | $1K-$15K |